Patient preferences for features of HER2-targeted treatment of advanced or metastatic breast cancer: a discrete-choice experiment study.
Carol A MansfieldWillings BothaGerard T VondelingKathleen KleinKongming WangJasmeet SinghMichelle D HackshawPublished in: Breast cancer (Tokyo, Japan) (2022)
Patients valued PFS gain higher than the potential risk of AEs when deciding between hypothetical breast cancer treatments.